|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.21 EUR | +2.11% |
|
-2.02% | +8.48% |
| 02:55pm | PHILIPS NV : UBS gives a Buy rating | ZD |
| 01-21 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| Capitalization | 23.48B 27.46B 21.8B 20.44B 37.92B 2,515B 40.61B 250B 98.99B 1,189B 103B 101B 4,343B | P/E ratio 2025 * |
31.1x | P/E ratio 2026 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise value | 28.62B 33.48B 26.57B 24.92B 46.23B 3,067B 49.5B 305B 121B 1,449B 126B 123B 5,294B | EV / Sales 2025 * |
1.61x | EV / Sales 2026 * | 1.55x |
| Free-Float |
81.81% | Yield 2025 * |
3.39% | Yield 2026 * | 3.38% |
Last Transcript: Philips NV
| 1 day | +2.11% | ||
| 1 week | -2.02% | ||
| Current month | +8.48% | ||
| 1 month | +10.04% | ||
| 3 months | +2.65% | ||
| 6 months | +19.59% | ||
| Current year | +8.48% |
| 1 week | 24.23 |  | 26.19 |
| 1 month | 22.6 | | 26.19 |
| Current year | 23.08 | | 26.19 |
| 1 year | 18.9 | | 27.63 |
| 3 years | 13.46 | | 30.22 |
| 5 years | 11.23 | | 47.19 |
| 10 years | 11.23 | | 47.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 52 | 15/10/2022 |
| Director of Finance/CFO | 48 | 01/10/2024 | |
Willem Appelo
COO | Chief Operating Officer | 62 | 18/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Paulus Stoffels
BRD | Director/Board Member | 63 | 01/01/2018 |
A. Harrison
BRD | Director/Board Member | 62 | 01/01/2018 |
Liz Doherty
BRD | Director/Board Member | 69 | 10/05/2019 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.32% | 0.99% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.11% | -2.02% | -1.21% | +71.92% | 27.46B | |
| +2.79% | +2.33% | +11.04% | +7.18% | 239B | |
| -0.71% | -4.22% | -13.31% | +103.95% | 186B | |
| +3.29% | +1.72% | -0.84% | -11.79% | 171B | |
| +0.56% | -2.17% | -9.12% | +101.03% | 136B | |
| +1.60% | -4.63% | -16.57% | -8.43% | 56.94B | |
| +2.01% | +2.45% | +21.68% | +7.38% | 49.41B | |
| +2.90% | -4.21% | -8.39% | -10.36% | 39.62B | |
| +2.41% | -0.09% | +4.64% | +10.46% | 37.77B | |
| +2.88% | -4.92% | -7.14% | +21.46% | 36.94B | |
| Average | +1.50% | -2.04% | -1.92% | +29.28% | 97.98B | |
| Weighted average by Cap. | +1.35% | -1.00% | -1.58% | +36.11% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 17.77B 20.78B 16.49B 15.47B 28.69B 1,903B 30.73B 189B 74.9B 900B 77.92B 76.33B 3,286B | 17.94B 20.99B 16.66B 15.62B 28.98B 1,922B 31.03B 191B 75.64B 909B 78.7B 77.09B 3,319B |
| Net income | 752M 880M 698M 655M 1.21B 80.58B 1.3B 8.01B 3.17B 38.08B 3.3B 3.23B 139B | 1.05B 1.23B 976M 915M 1.7B 113B 1.82B 11.2B 4.43B 53.22B 4.61B 4.52B 194B |
| Net Debt | 5.14B 6.02B 4.78B 4.48B 8.31B 551B 8.9B 54.81B 21.69B 260B 22.56B 22.1B 951B | 4.35B 5.08B 4.03B 3.78B 7.02B 466B 7.52B 46.3B 18.32B 220B 19.06B 18.67B 804B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/01/26 | 25.21 € | +2.11% | 117,785 |
| 21/01/26 | 24.69 € | +1.44% | 1,243,328 |
| 20/01/26 | 24.34 € | -0.61% | 1,105,964 |
| 19/01/26 | 24.49 € | -4.49% | 1,711,300 |
| 16/01/26 | 25.64 € | -1.69% | 1,195,038 |
Real-time Euronext Amsterdam, January 22, 2026 at 04:19 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PHIA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition